-
Product Insights
Peripheral Vascular Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Peripheral Vascular Devices Pipeline Market Report Overview Peripheral vascular devices are used to treat peripheral vascular disease (PVD). The Peripheral Vascular Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments · Peripheral Vascular Stents · ...
-
Product Insights
Neurosurgical Products Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Neurosurgical Products Pipeline Market Report Overview The neurosurgical products pipeline market research report provides comprehensive information about the neurosurgical products pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments · Dura Substitutes · Neuroendoscopes · Neurosurgical Drills · Synthetic Dura Substitutes · Neurosurgical Drills · Biological Dura Substitutes Key Territories · The US · Europe · Canada · Israel · Japan · Philippines...
-
Company Profile
Elite Pharmaceuticals Inc – Company Profile
Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company that focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs upon marketing approvals via Abbreviated New Drug Applications (ANDA) and branded drugs via New Drug Application (NDA) for the treatment of cardiovascular disorders, allergies, infections, bariatric and others. Its key commercialized product portfolio include Adipex-P, Bontril for Bariatric therapy; Revia for Pain related; Dantrium for muscle relaxation; Adderall XR for central...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (naltrexone hydrochloride + oxycodone hydrochloride) SR
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (naltrexone hydrochloride + oxycodone hydrochloride) SR Drug Details A fixed dose combination of naltrexone...
-
Product Insights
Osteoarthritis Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Osteoarthritis Pain Pipeline Drugs Market Overview Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain – Drugs In Development, 2022, provides an overview of the Osteoarthritis Pain (Central Nervous System) pipeline landscape. Osteoarthritis Pain Pipeline Drugs Market is the most common symptom associated with osteoarthritis which causes disruption of the cartilage. If the condition worsens, it leads to rubbing of the bones against each other causing even more pain and loss of movement. Risk factors are age, joint...
-
Product Insights
Opium Withdrawal Syndrome Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Opium Withdrawal Syndrome Global Clinical Trials Review, H1, 2018" provides an overview of Opium Withdrawal Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Opium Withdrawal Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...